Last reviewed · How we verify
NCT07429409
Cancer Risk Factor Knowledge Among Teenagers in Slovenia
NA trial testing Cancer Risk Factor Knowledge Questionnaire in Cancer Prevention in 795 participants. Completed in 1 May 2024.
31 March 2022
Quick facts
| Lead sponsor | Institute of Oncology Ljubljana |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 795 |
| Start date | 1 December 2021 |
| Primary completion | 31 March 2022 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
- Cancer Risk Factor Knowledge Questionnaire
Conditions studied
- Cancer Prevention — all drugs for Cancer Prevention →
- Cancer Risk Factors — all drugs for Cancer Risk Factors →
Sponsor
Institute of Oncology Ljubljana
Who can join
Adults 12 to 18, any sex, with Cancer Prevention or Cancer Risk Factors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This interventional behavioral study evaluates knowledge of cancer risk factors among teenagers in Slovenia. Students aged 12 to 18 years from the final years of primary school and all years of secondary school are assigned to complete a structured Cancer Risk Factor Knowledge Questionnaire as part of a prevention-oriented educational assessment intervention. The study measures baseline knowledge of modifiable cancer risk factors within this defined adolescent population. The findings are intended to inform the development of targeted cancer prevention and health education strategies for adolescents in Slovenia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07429409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer Prevention
Currently open trials in the same condition.
- NCT07219706 — Dietary Fiber and Time Restricted Eating · NA · recruiting
- NCT07225881 — Eatwell Clinical Trial (R01) · NA · recruiting
- NCT07501689 — Using Middle School Science Teachers to Address Cancer Health Disparities · NA · recruiting
- NCT07086833 — The Food Environment, Microbial Cysteine Metabolism, and Cancer Disparities · NA · recruiting
- NCT06421324 — Personalised Health Recommendations to the General Population Through an Integrated AI Guided · NA · recruiting
Other Institute of Oncology Ljubljana trials
Trials by the same sponsor.
- NCT06923787 — Effect of Perioperative Intravenous Infusion of Lidocaine on the Postoperative Course and the Immune Response in Patient · Phase 2 · recruiting
- NCT07432399 — Effect of Perioperative Lidocaine or High-Dose Dexamethasone on Immune Response in Colon Cancer Surgery (PILDI Study) · Phase 2 · recruiting
- NCT06650423 — Adherence to Aromatase Inhibitors ± Abemaciclib Treatment in Patients With Early-stage HER2-negative Breast Cancer · recruiting
- NCT07420647 — Pilot Study of Individualized Treatment for Genitourinary Syndrome of Menopause in Women After Cancer Treatment · NA · active not recruiting
- NCT07416500 — BRCA1, RASSF1A and PTEN Methylation in Breast Lesions of Uncertain Malignant Potential · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07429409 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Institute of Oncology Ljubljana
- Last refreshed: 24 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07429409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing